Concepedia

Camus Nimmo

CN

17

Publications

2K

Citations

14

H-Index

2011

Active since

Affiliations

University College London(Current)

London School of Hygiene & Tropical Medicine

University of Oxford

Africa Health Research Institute

Imperial College London

Camus Nimmo is an author at University College London specializing in medicine, tuberculosis, and drug resistance.

ORCID

Top concepts

Publications per year

2011–2024

17

Publications

17

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 516 citations · Full text

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2022 · 382 citations · Full text

, , +3

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 289 citations · Full text

The 2021 WHO catalogue of Mycobacterium tuberculosis complex mutations associated with drug resistance: a genotypic analysis

Paolo Miotto, Claudio U. Köser, Philip W. Fowler et al. · The Lancet Microbe · 2022 · 282 citations · Full text

Population-level emergence of bedaquiline and clofazimine resistance-associated variants among patients with drug-resistant tuberculosis in southern Africa: a phenotypic and phylogenetic analysis

Camus Nimmo, James Millard, Lucy van Dorp et al. · The Lancet Microbe · 2020 · 104 citations · Full text

Rows per page

1–5 of 17